204 related articles for article (PubMed ID: 18037123)
1. Ifosfamide induces acute renal failure via inhibition of the thioredoxin reductase activity.
Zhang J; Lu H
Free Radic Biol Med; 2007 Dec; 43(12):1574-83. PubMed ID: 18037123
[TBL] [Abstract][Full Text] [Related]
2. Cyclophosphamide as a potent inhibitor of tumor thioredoxin reductase in vivo.
Wang X; Zhang J; Xu T
Toxicol Appl Pharmacol; 2007 Jan; 218(1):88-95. PubMed ID: 17156807
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of glutathione synthesis eliminates the adaptive response of ascitic hepatoma 22 cells to nedaplatin that targets thioredoxin reductase.
Wang Y; Lu H; Wang D; Li S; Sun K; Wan X; Taylor EW; Zhang J
Toxicol Appl Pharmacol; 2012 Dec; 265(3):342-50. PubMed ID: 22982619
[TBL] [Abstract][Full Text] [Related]
5. Melatonin attenuates ifosfamide-induced Fanconi syndrome in rats.
Sener G; Sehirli O; Yegen BC; Cetinel S; Gedik N; Sakarcan A
J Pineal Res; 2004 Aug; 37(1):17-25. PubMed ID: 15230864
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of thioredoxin reductase but not of glutathione reductase by the major classes of alkylating and platinum-containing anticancer compounds.
Witte AB; Anestål K; Jerremalm E; Ehrsson H; Arnér ES
Free Radic Biol Med; 2005 Sep; 39(5):696-703. PubMed ID: 16085187
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin reductase inactivation as a pivotal mechanism of ifosfamide in cancer therapy.
Wang X; Zhang J; Xu T
Eur J Pharmacol; 2008 Jan; 579(1-3):66-73. PubMed ID: 18028906
[TBL] [Abstract][Full Text] [Related]
8. Amifostine increases cure rate of cisplatin on ascites hepatoma 22 via selectively protecting renal thioredoxin reductase.
Zhang J; Wang X; Lu H
Cancer Lett; 2008 Feb; 260(1-2):127-36. PubMed ID: 18039557
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide-induced nephrotoxicity: mechanism and prevention.
Nissim I; Horyn O; Daikhin Y; Nissim I; Luhovyy B; Phillips PC; Yudkoff M
Cancer Res; 2006 Aug; 66(15):7824-31. PubMed ID: 16885387
[TBL] [Abstract][Full Text] [Related]
10. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1).
Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC
Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263
[TBL] [Abstract][Full Text] [Related]
11. Mechanism-based inactivation of thioredoxin reductase from Plasmodium falciparum by Mannich bases. Implication for cytotoxicity.
Davioud-Charvet E; McLeish MJ; Veine DM; Giegel D; Arscott LD; Andricopulo AD; Becker K; Müller S; Schirmer RH; Williams CH; Kenyon GL
Biochemistry; 2003 Nov; 42(45):13319-30. PubMed ID: 14609342
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol improves ifosfamide-induced Fanconi syndrome in rats.
Sehirli O; Sakarcan A; Velioğlu-Oğünç A; Cetinel S; Gedik N; Yeğen BC; Sener G
Toxicol Appl Pharmacol; 2007 Jul; 222(1):33-41. PubMed ID: 17481685
[TBL] [Abstract][Full Text] [Related]
13. The thioredoxin reductase inhibitor auranofin triggers apoptosis through a Bax/Bak-dependent process that involves peroxiredoxin 3 oxidation.
Cox AG; Brown KK; Arner ES; Hampton MB
Biochem Pharmacol; 2008 Oct; 76(9):1097-109. PubMed ID: 18789312
[TBL] [Abstract][Full Text] [Related]
14. Efforts to establish an animal model of Fanconi syndrome after ifosfamide administration to rats.
Appenroth D; Werner T; Lupp A; Patzer L; Misselwitz J; Fleck C
J Appl Toxicol; 2007; 27(4):327-36. PubMed ID: 17265418
[TBL] [Abstract][Full Text] [Related]
15. The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells.
Chen N; Aleksa K; Woodland C; Rieder M; Koren G
Transl Res; 2007 Jul; 150(1):51-7. PubMed ID: 17585863
[TBL] [Abstract][Full Text] [Related]
16. Reductive activation of ricin and ricin A-chain immunotoxins by protein disulfide isomerase and thioredoxin reductase.
Bellisola G; Fracasso G; Ippoliti R; Menestrina G; Rosén A; Soldà S; Udali S; Tomazzolli R; Tridente G; Colombatti M
Biochem Pharmacol; 2004 May; 67(9):1721-31. PubMed ID: 15081871
[TBL] [Abstract][Full Text] [Related]
17. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity.
Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ
Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of thioredoxin reductase induces apoptosis in neuronal cell lines: role of glutathione and the MKK4/JNK pathway.
Seyfried J; Wüllner U
Biochem Biophys Res Commun; 2007 Aug; 359(3):759-64. PubMed ID: 17559804
[TBL] [Abstract][Full Text] [Related]
20. Taurine attenuates fanconi syndrome induced by ifosfamide without compromising its antitumor activity.
Badary OA
Oncol Res; 1998; 10(7):355-60. PubMed ID: 10063969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
